Is cervical cancer screening accurate?

Cervical cancer screening is primarily used to detect precancerous lesions and early-stage cervical cancer. The accuracy of such screening depends on various factors, including the method used for the examination, the standard procedures followed during the testing, and the pathological diagnosis results.

Liquid-based thin-layer cytology is one of the commonly used methods for cervical cancer screening at present, and it possesses relatively high sensitivity and specificity. Liquid-based cytology involves using a special fluid to preserve exfoliated cervical cells, which are then processed by machinery to create thin cell samples. This method reduces interference from factors such as blood and mucus that can affect traditional Pap smear results, thereby improving the detection rate of abnormal cells. This method achieves a relatively satisfactory detection rate for high-grade squamous intraepithelial lesions, but there may be a certain risk of missing low-grade lesions. HPV testing, as another important method for cervical cancer screening, primarily detects infections caused by high-risk types of human papillomavirus. HPV testing is more sensitive than cytological examinations and can detect some individuals at high risk who test negative in cytology tests. However, its specificity is relatively lower; some transient HPV infections may resolve on their own without any clinical significance. Sexual intercourse, vaginal douching, or the use of any medications should be avoided within 72 hours prior to the screening. It is also not appropriate to undergo the examination during menstruation, as these factors may affect the quality of the sample. When there are abnormalities in the appearance of the cervix, it is necessary to combine colposcopy with biopsies to improve the accuracy of the diagnosis.

The accuracy of cervical cancer screening has certain limitations. Cytological examinations may vary in interpretation depending on the experience of the reader, and insufficient sampling or improper site selection can lead to false-negative results. For postmenopausal women or those with abnormal cervical anatomy, the increased difficulty in obtaining samples may affect the accuracy of the test results. Although HPV tests are highly sensitive, they cannot distinguish between persistent and transient infections, nor can they directly determine whether any lesions are present. The interval between screenings also affects the effectiveness of detection; too long an interval may result in missing the optimal timing for intervention. In some specific pathological types, such as cervical adenocarcinoma, the cellular characteristics may be atypical, which can increase the difficulty of diagnosis.

It is recommended that women over 21 years of age or those with a history of sexual activity undergo regular cervical cancer screening. For women over 30 years of age, combining cytological tests with HPV testing can improve the accuracy of the screening results. Individuals with abnormal screening results should undergo colposcopy or pathological biopsy as prescribed by their doctor for a definitive diagnosis. Maintaining cleanliness and hygiene of the external genital area on a daily basis, avoiding multiple sexual partners, and receiving the HPV vaccine can serve as primary preventive measures. If abnormal vaginal bleeding or discharge occurs, it is important to seek medical attention promptly; one should not rely solely on screening results to assess their health status.